NCT00295412View on ClinicalTrials.gov

The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
SchizophreniaSubstance Use Disorders
Interventions
DRUG

quetiapine (drug)

Trial Locations (1)

H1N 3V2

Centre de recherche Fernand-Seguin, Montreal

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Université de Montréal

OTHER

NCT00295412 - The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients | Biotech Hunter | Biotech Hunter